Bharat Biotech signs pact to supply 20 million doses of Covaxin to Brazil
NEW DELHI: Bharat Biotech will supply 20 million doses of its COVID-19 vaccine Covaxin to Brazil during the second and third quarters of current year, the city-based vaccine maker said on Friday.
It has signed an agreement with the Brazilian government for the supply of the indigenously developed vaccine, a press release from the company said here.
Delighted to partner with Brazil in the unified fight against COVID-19. 20 million doses of COVAXIN® to be supplied.#BharatBiotech #COVAXIN #COVID19Vaccine #COVID19 #VaccinesWork #Partnership#SARSCoV2 #Vaccinesaveslife pic.twitter.com/11xitz7ANU
— Bharat Biotech (@BharatBiotech) February 26, 2021
“The company is delighted to partner with Brazil in its battle against Covid-19 and aid its immunisation programme against the virus. It has signed an agreement for delivery of Covaxin during Q2 and Q3 2021,” it said.
Several countries around the world have expressed strong interest in Covaxin and the company was fully committed to ensuring supplies promptly and efficiently, the release added.
Bharat Biotech had earlier saidit signed an agreement with Brazil-based Precisa Medicamentos for the supplies of Covaxin for the private markets inthe South American country.
Source: Press Trust of India
